$0.381
-0.0189 (-4.73%)
At Close: Jun 05, 2026
Elite Pharmaceuticals, Inc. (ELTP) Q4 2024 Earnings Call Transcript
08:47pm, Tuesday, 02'nd Jul 2024
Elite Pharmaceuticals, Inc. (OTCQB:ELTP) Q4 2024 Earnings Conference Call July 2, 2024 11:30 AM ET Company Participants Nasrat Hakim - President and CEO Carter Ward - CFO, Secretary and Treasurer Conf
Elite Pharmaceuticals' (ELTP) FY24 Earnings Up, Gross Margin Down
12:45pm, Tuesday, 02'nd Jul 2024
Elite Pharmaceuticals' (ELTP) overall top line benefits from revenue growth in Manufacturing fees.
Conference Call Scheduled for Tuesday, July 2 at 11:30 AM EDT Northvale, New Jersey--(Newsfile Corp. - July 1, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty
Financials for Fiscal Year 2024 Ended March 31, 2024 will be released on July 1, 2024 Northvale, New Jersey--(Newsfile Corp. - June 26, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or th
7 Strong Buy Penny Stocks to Buy Now: June 2024
06:32am, Thursday, 13'th Jun 2024
There are thousands of U.S.-listed stocks categorized as penny stocks, or stocks trading for $5 per share or less but only a few can be considered strong buy penny stocks. “Penny stock territory”
Elite Pharmaceuticals Receives FDA Approval for Generic Methotrexate
06:00am, Monday, 20'th May 2024
NORTHVALE, NJ / ACCESSWIRE / May 20, 2024 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today announced t
Elite Pharmaceuticals, Inc. (ELTP) Q3 2024 Earnings Call Transcript
02:44pm, Thursday, 15'th Feb 2024
Elite Pharmaceuticals, Inc. (ELTP) Q3 2024 Earnings Call Transcript
Conference Call Scheduled for Thursday, February 15 at 11:30 AM EST NORTHVALE, NJ / ACCESSWIRE / February 14, 2024 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company")(OTCBB:ELTP), a specialty pha
Financials for Third Quarter Fiscal Year 2024 Ended December 31, 2023 will be released on February 14, 2024 NORTHVALE, NJ / ACCESSWIRE / February 8, 2024 / Elite Pharmaceuticals, Inc. ("Elite" or the
Elite Pharmaceuticals Files ANDA with US FDA to Market Central Nervous System Stimulant
07:00am, Tuesday, 26'th Dec 2023
NORTHVALE, NJ / ACCESSWIRE / December 26, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP), a specialty pharmaceutical company engaged in the development, manufacture, and di
Elite Pharmaceuticals Announces First Product Shipment of Generic Adderall XR(R) to Marketing Partner Prasco, LLC
07:00am, Tuesday, 12'th Dec 2023
NORTHVALE, NJ / ACCESSWIRE / December 12, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today announ
Small Stocks, Big Potential: 7 Penny Stocks Poised for Major Gains in 2024
09:01am, Monday, 04'th Dec 2023
The equities market can feel like navigating through a fog while searching for the best penny stocks. Yet, amidst this uncertainty, a handful of names emerge as clear winners, displaying robust resili
Elite Pharmaceuticals, Inc. (ELTP) Q2 2024 Earnings Call Transcript
01:13pm, Friday, 17'th Nov 2023
Elite Pharmaceuticals, Inc. (OTCQB:ELTP) Q2 2024 Earnings Call Transcript November 15, 2023 11:30 AM ET Company Participants Nasrat Hakim - President and Chief Executive Officer Carter Ward - Chief Fi
Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone
12:32pm, Thursday, 16'th Nov 2023 InvestorsHub
Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone The U.S. Navy is looking to use the ZenaDrone 1000 for a variety of missions, including surveillance, search and rescue and reconnaissance. Miami, FL -- (InvestorsHub NewsWire - November 16, 2023) - EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies, reports on Epazz, Inc. (OTC Pink: EPAZ). &n...
Conference Call Scheduled for Wednesday, November 15 at 11:30 AM EST NORTHVALE, NJ / ACCESSWIRE / November 14, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty p
Sign In
Buy ELTP